Remnant Cholesterol, a Valuable Biomarker for Assessing Arteriosclerosis and Cardiovascular Risk: A Systematic Review

Overview

Journal Cureus

Specialty Biomedical Engineering

Date 2023 Sep 28

PMID 37767252

Authors

Xiang Chen

Li-Hua Li

Affiliations

Soon will be listed here.

Abstract

Arteriosclerosis, as the foundation for the development of cardiovascular diseases, is influenced by disturbances in lipid metabolism. Extensive research has consistently shown a correlation between conventional lipid parameters, arteriosclerosis, and cardiovascular diseases. Guidelines highlight the importance of targeting low-density lipoprotein cholesterol (LDL-C) for primary and secondary prevention of cardiovascular diseases, with reducing LDL-C remaining the primary lipid-lowering strategy. However, even when LDL-C is lowered to optimal levels, there is a residual risk of cardiovascular disease. Recent findings have brought attention to remnant cholesterol (RC) as a significant factor contributing to this residual risk. The close association between RC, arteriosclerosis, and cardiovascular diseases presents exciting opportunities for lifestyle interventions and medical treatments to control and lower RC levels, offering new targets for preventing and managing related cardiovascular conditions. Our systematic review sheds light on the importance of considering RC as a valuable biomarker in assessing arteriosclerosis and its potential impact on cardiovascular health. By understanding the link between remnant cholesterol and arteriosclerosis, researchers and healthcare professionals can develop targeted interventions to mitigate cardiovascular risks, thus improving public health outcomes and reducing the economic burden associated with cardiovascular diseases.

Citing Articles

Reduction in Remnant Cholesterol in Obese Individuals After Bariatric Surgery with Gastric Bypass or Sleeve Gastrectomy.

Aaseth J, Retterstol K, Rootwelt H, Farup P Nutrients. 2025; 17(1.

PMID: 39796622 PMC: 11723409. DOI: 10.3390/nu17010189.

Causal association between remnant cholesterol level and risk of cardiovascular diseases: a bidirectional two sample mendelian randomization study.

Zhong L, Xie B, Wang H, Ji X Sci Rep. 2024; 14(1):27038.

PMID: 39511362 PMC: 11544147. DOI: 10.1038/s41598-024-78610-0.

Gender-specific correlations between remnant cholesterol and severe abdominal aortic calcification in American adults.

Yan L, Hu X, Wu S, Zhao S Front Endocrinol (Lausanne). 2024; 15:1415424.

PMID: 39351538 PMC: 11439657. DOI: 10.3389/fendo.2024.1415424.

Remnant cholesterol and the risk of carotid plaque in hypertension: results from a community-based screening among old adults in Hangzhou, China.

Yu Z, Yang H, Shou B, Cheng Z, Jiang C, Ye Y Sci Rep. 2024; 14(1):8407.

PMID: 38600230 PMC: 11006856. DOI: 10.1038/s41598-024-58484-y.

Cumulative residual cholesterol predicts the risk of cardiovascular disease in the general population aged 45 years and older.

Zhao M, Xiao M, Tan Q, Ji J, Lu F Lipids Health Dis. 2024; 23(1):19.

PMID: 38243226 PMC: 10797780. DOI: 10.1186/s12944-023-02000-0.

References

Wang L, Zhi F, Gao B, Ni J, Liu Y, Mo X . Association between lipid profiles and arterial stiffness: A secondary analysis based on a cross-sectional study. J Int Med Res. 2020; 48(7):300060520938188. PMC: 7383716. DOI: 10.1177/0300060520938188. View

Zhan B, Huang X, Wang J, Qin X, Zhang J, Cao J . Association Between Lipid Profiles and Arterial Stiffness in Chinese Patients With Hypertension: Insights From the CSPPT. Angiology. 2019; 70(6):515-522. DOI: 10.1177/0003319718823341. View

Laurent S, Katsahian S, Fassot C, Tropeano A, Gautier I, Laloux B . Aortic stiffness is an independent predictor of fatal stroke in essential hypertension. Stroke. 2003; 34(5):1203-6. DOI: 10.1161/01.STR.0000065428.03209.64. View

Gkaliagkousi E, Lazaridis A, Dogan S, Fraenkel E, Guvenc Tuna B, Mozos I . Theories and Molecular Basis of Vascular Aging: A Review of the Literature from VascAgeNet Group on Pathophysiological Mechanisms of Vascular Aging. Int J Mol Sci. 2022; 23(15). PMC: 9368987. DOI: 10.3390/ijms23158672. View

Musunuru K, Kathiresan S . Surprises From Genetic Analyses of Lipid Risk Factors for Atherosclerosis. Circ Res. 2016; 118(4):579-85. PMC: 4762058. DOI: 10.1161/CIRCRESAHA.115.306398. View

Chen P, Gao W, Liou J, Lin C, Wu M, Yen J . Angiopoietin-Like Protein 3 (ANGPTL3) Modulates Lipoprotein Metabolism and Dyslipidemia. Int J Mol Sci. 2021; 22(14). PMC: 8304944. DOI: 10.3390/ijms22147310. View

Park H, Kang M, Kim K, Koh J, Park J, Hwang S . Prognostic value of brachial-ankle pulse wave velocity in patients with non-ST-elevation myocardial infarction. Coron Artery Dis. 2017; 28(8):642-648. DOI: 10.1097/MCA.0000000000000529. View

Jorgensen A, Frikke-Schmidt R, West A, Grande P, Nordestgaard B, Tybjaerg-Hansen A . Genetically elevated non-fasting triglycerides and calculated remnant cholesterol as causal risk factors for myocardial infarction. Eur Heart J. 2012; 34(24):1826-33. DOI: 10.1093/eurheartj/ehs431. View

Segers P, Rietzschel E, Chirinos J . How to Measure Arterial Stiffness in Humans. Arterioscler Thromb Vasc Biol. 2019; 40(5):1034-1043. PMC: 7180118. DOI: 10.1161/ATVBAHA.119.313132. View

10.

Vasan R, Pan S, Larson M, Mitchell G, Xanthakis V . Arteriosclerosis, Atherosclerosis, and Cardiovascular Health: Joint Relations to the Incidence of Cardiovascular Disease. Hypertension. 2021; 78(5):1232-1240. PMC: 8516717. DOI: 10.1161/HYPERTENSIONAHA.121.18075. View

11.

Laurent S, Cockcroft J, van Bortel L, Boutouyrie P, Giannattasio C, Hayoz D . Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J. 2006; 27(21):2588-605. DOI: 10.1093/eurheartj/ehl254. View

12.

Hoogeveen R, Ballantyne C . Residual Cardiovascular Risk at Low LDL: Remnants, Lipoprotein(a), and Inflammation. Clin Chem. 2020; 67(1):143-153. PMC: 7793228. DOI: 10.1093/clinchem/hvaa252. View

13.

Anderson R, Evans M, Ellis G, Graham J, Morris K, Jackson S . The relationships between post-prandial lipaemia, endothelial function and oxidative stress in healthy individuals and patients with type 2 diabetes. Atherosclerosis. 2001; 154(2):475-83. DOI: 10.1016/s0021-9150(00)00499-8. View

14.

Varbo A, Benn M, Tybjaerg-Hansen A, Nordestgaard B . Elevated remnant cholesterol causes both low-grade inflammation and ischemic heart disease, whereas elevated low-density lipoprotein cholesterol causes ischemic heart disease without inflammation. Circulation. 2013; 128(12):1298-309. DOI: 10.1161/CIRCULATIONAHA.113.003008. View

15.

Baba M, Maris M, Jianu D, Luca C, Stoian D, Mozos I . The Impact of the Blood Lipids Levels on Arterial Stiffness. J Cardiovasc Dev Dis. 2023; 10(3). PMC: 10056627. DOI: 10.3390/jcdd10030127. View

16.

Tesauro M, Mauriello A, Rovella V, Annicchiarico-Petruzzelli M, Cardillo C, Melino G . Arterial ageing: from endothelial dysfunction to vascular calcification. J Intern Med. 2017; 281(5):471-482. DOI: 10.1111/joim.12605. View

17.

Johansen C, Kathiresan S, Hegele R . Genetic determinants of plasma triglycerides. J Lipid Res. 2010; 52(2):189-206. PMC: 3023540. DOI: 10.1194/jlr.R009720. View

18.

Wang Z, Li M, Xie J, Gong J, Liu N . Association between remnant cholesterol and arterial stiffness: A secondary analysis based on a cross-sectional study. J Clin Hypertens (Greenwich). 2021; 24(1):26-37. PMC: 8783357. DOI: 10.1111/jch.14384. View

19.

Ginsberg H, Packard C, Chapman M, Boren J, Aguilar-Salinas C, Averna M . Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies-a consensus statement from the European Atherosclerosis Society. Eur Heart J. 2021; 42(47):4791-4806. PMC: 8670783. DOI: 10.1093/eurheartj/ehab551. View

20.

Teramoto R, Tada H, Kawashiri M, Nohara A, Nakahashi T, Konno T . Molecular and functional characterization of familial chylomicronemia syndrome. Atherosclerosis. 2017; 269:272-278. DOI: 10.1016/j.atherosclerosis.2017.11.006. View